Latest Asx News

FirstWave Cloud Technology reports a cashflow positive first half of FY25, driven by strategic contract renewals and new technology launches, despite a slight decline in recurring revenue due to customer churn.

New World Resources Limited has completed a significant reserve definition drilling program at its Antler Copper Project, alongside key permitting progress and accelerated funding discussions, setting the stage for a definitive feasibility study in 2025.

88 Energy Limited announces a maiden internal Prospective Resource estimate of 283 million barrels of oil for its Canning Prospect at Project Leonis, Alaska, with plans to drill the Tiri-1 exploration well targeting multiple reservoirs in 2026.

Argenica Therapeutics has dosed 80% of patients in its Phase 2 stroke trial and gained FDA orphan drug designations for its second candidate, ARG-006. The company reports a cash-positive quarter with $15 million in reserves.

ioneer Ltd’s December 2024 quarterly cash flow report reveals ongoing cash outflows from operations and investing, with nearly $4.5 million spent this quarter but a solid cash reserve providing a runway of almost five quarters.

Kingsrose Mining, in alliance with BHP, reports promising high-grade copper and polymetallic discoveries in Norway and Finland, advancing one of Europe’s largest exploration programs.

Saturn Metals has engaged global heap leach engineering leader Kappes Cassiday & Associates to complete the Pre-Feasibility Study for its Apollo Hill Gold Project, marking a pivotal step in advancing the project’s development.

Nanoveu Limited has appointed industry veteran Mark Goranson as CEO of its Semiconductor Technologies division, positioning the company to accelerate growth in ultra-low-power AI-driven chips following its EMASS acquisition.

Ioneer Ltd has closed a $996 million loan from the U.S. Department of Energy to accelerate its Rhyolite Ridge Lithium-Boron Project in Nevada, following key federal permitting milestones. Construction is targeted for 2025, promising to boost domestic critical mineral supply and create hundreds of jobs.

Tryptamine Therapeutics has reported successful Phase 1b results for its IV-infused psilocin candidate TRP-8803 and promising interim data for oral psilocybin TRP-8802 in IBS treatment, while securing $6 million in new funding to accelerate clinical development.

Godolphin Resources has completed its first phase of drilling at Lewis Ponds, intersecting significant massive and semi-massive sulphide mineralisation that could underpin an upgrade to its existing resource estimate.

A1 Investments & Resources Ltd reported a modest cash outflow for Q1 2024 while actively pursuing renewable energy acquisitions in Japan and Australia, contingent on regulatory approvals and shareholder consent.